
P21 (P021)
CNTF-derived peptide.
- Sizes available
- 10mg
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
CNTF mimetic. Neurotrophic / Alzheimer's animal research.
Mechanism · Ciliary Neurotrophic Factor (CNTF) analog peptide. Pre-clinical.
Best for. Not for.
Best for
- Neurotrophic factor research
- Users following Alzheimer's animal-model literature
- Pre-clinical experimental peptide users
Not for
- Human Phase X clinical not established. Animal only
- Pregnancy or nursing
- Active malignancy (neurogenesis proliferation theoretical)
Mechanism, dose, ramp, risk.
- Mechanism
- Adenosine-modified peptide. Studied for Alzheimer's animal models.Source · PEPVERA editorial
- Target dose
- Research-only.Source · PEPVERA editorial
- Ramp
- Slow.Source · PEPVERA editorial
- Risks
- Limited human data.Source · PEPVERA editorial
Compared to its siblings.
P21 (P021)
CNTF mimetic. Neurotrophic / Alzheimer's animal research.
Pros
- · Distinct mechanism from FGL's NCAM mimicry.
- · No IM injection required, unlike cerebrolysin.
Cons
- · No NCAM-specific targeting like FGL.
- · No 50+ country approval like cerebrolysin.
FGL (FG-loop)
NCAM mimetic. Different mechanism.
Pros
- · Specific NCAM
Cons
- · Same pre-clinical
See FGL (FG-loop) →
Cerebrolysin
EU approved. Western clinical.
Pros
- · 50+ Country
Cons
- · IM injection
See Cerebrolysin →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 1 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Verified PeptidesUS | $119$11.90/mg · 10mg | Sample COA published | 3 days | Out of stock |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
Research-only.
Initiation
Week 3–4
Research-only.
Signal emerges
Week 5–8
Research-only.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
0.5 mg = 0.20 mL at 2.50 mg/mL. 10.0 doses per vial.
mind · IV
P21 (P021) · 5mg